6 results on '"Teagan L. Brown"'
Search Results
2. A hybrid and poly-polish workflow for the complete and accurate assembly of phage genomes: a case study of ten przondoviruses
- Author
-
Claire K. A. Elek, Teagan L. Brown, Thanh Le Viet, Rhiannon Evans, David J. Baker, Andrea Telatin, Sumeet K. Tiwari, Haider Al-Khanaq, Gaëtan Thilliez, Robert A. Kingsley, Lindsay J. Hall, Mark A. Webber, and Evelien M. Adriaenssens
- Abstract
Bacteriophages (phages) within thePrzondovirusgenus are T7-like podoviruses belonging to theStudiervirinaesubfamily, within theAutographiviridaefamily and have a highly conserved genome organisation. The genome size of these phages ranges from 37 kb to 42 kb, encode 50-60 genes and are characterised by the presence of direct terminal repeats (DTRs) flanking the linear chromosome. These DTRs are often deleted during short-read-only and hybrid assemblies. Moreover, long-read-only assemblies are often littered with sequencing and/or assembly errors and require additional curation. Here, we present the isolation and characterisation of ten novel przondoviruses targetingKlebsiellaspp. We describe HYPPA – aHYbrid andPoly-polishPhageAssembly workflow, which utilises long-read assemblies in combination with short-read sequencing to resolve phage DTRs and correcting errors, negating the need for laborious primer walking and Sanger sequencing validation. Our data demonstrate the importance of careful curation of phage assemblies before publication, and prior to using them for comparative genomics.IMPACT STATEMENTThe current workflows employed for phage genome assembly are often error-prone and can lead to many incomplete phage genomes being deposited within databases. This can create challenges when performing comparative genomics, and may also lead to incorrect taxonomic assignment. To overcome these challenges we proposed HYPPA, a workflow that can produce complete and high-quality phage genomes without the need for laborious lab-based validation.DATA SUMMARYPhage raw reads are available from the National Centre for Biotechnology Information Sequence Read Archive (NCBI-SRA) under the BioProject number PRJNA914245. Phage annotated genomes have been deposited at GenBank under the accessionsOQ579023-OQ579032(Table 1). Bacterial WGS data for clinical preterm infant samples have been deposited at GenBank under BioProject accession PRJNA471164 (Table S1). Bacterial raw reads for food samples are available from NCBI-SRA with individual accessions (SAMN33593347-SAMN33593351), and can be found under the BioProject number PRJNA941224 (Table S1). Strain-specific details for bacteria and publicly-available phages used in these analyses, along with accessions for the latter can be found inTable S1andTable S6, respectively. The CL1-CL8 clinicalKlebsiellastrains (Table S1) were under a Materials Transfer Agreement, for which sequencing data and strain information is not available.
- Published
- 2023
- Full Text
- View/download PDF
3. Locating and activating molecular 'time bombs': induction of Mycolata prophages
- Author
-
Teagan L. Brown, Stephen R. Doyle, Joseph Tucci, Robert J. Seviour, Steve Petrovski, Zoe A. Dyson, and Ben Farrar
- Subjects
0301 basic medicine ,Tsukamurella ,Prophages ,lcsh:Medicine ,Protein Sequencing ,medicine.disease_cause ,Genome ,Nocardia ,Mycolic acid ,Database and Informatics Methods ,Rhodococcus ,Bacteriophages ,Gordonia Bacterium ,lcsh:Science ,Uncategorized ,chemistry.chemical_classification ,Genetics ,Viral Genomics ,Multidisciplinary ,Sewage ,Chromosome Mapping ,Genomics ,Genomic Databases ,Gordonia malaquae ,Viruses ,Sequence Analysis ,Research Article ,food.ingredient ,Sequence Databases ,Genome, Viral ,Microbial Genomics ,Biology ,Gordonia ,Research and Analysis Methods ,Microbiology ,Evolution, Molecular ,03 medical and health sciences ,food ,Caudovirales ,Sequence Motif Analysis ,Virology ,Actinomycetales ,medicine ,Molecular Biology Techniques ,Sequencing Techniques ,Molecular Biology ,DNA sequence analysis ,Prophage ,lcsh:R ,Organisms ,Biology and Life Sciences ,Computational Biology ,Genome Analysis ,biology.organism_classification ,Mutagenesis, Insertional ,Biological Databases ,030104 developmental biology ,chemistry ,Virus Activation ,lcsh:Q - Abstract
Little is known about the prevalence, functionality and ecological roles of temperate phages for members of the mycolic acid producing bacteria, the Mycolata. While many lytic phages infective for these organisms have been isolated, and assessed for their suitability for use as biological control agents of activated sludge foaming, no studies have investigated how temperate phages might be induced for this purpose. Bioinformatic analysis using the PHAge Search Tool (PHAST) on Mycolata whole genome sequence data in GenBank for members of the genera Gordonia, Mycobacterium, Nocardia, Rhodococcus, and Tsukamurella revealed 83% contained putative prophage DNA sequences. Subsequent prophage inductions using mitomycin C were conducted on 17 Mycolata strains. This led to the isolation and genome characterization of three novel Caudovirales temperate phages, namely GAL1, GMA1, and TPA4, induced from Gordonia alkanivorans, Gordonia malaquae, and Tsukamurella paurometabola, respectively. All possessed highly distinctive dsDNA genome sequences.
- Published
- 2023
- Full Text
- View/download PDF
4. The formulation of bacteriophage in a semi solid preparation for control of Propionibacterium acnes growth
- Author
-
Zoe A. Dyson, Teagan L. Brown, Robert J. Seviour, Joseph Tucci, and Steve Petrovski
- Subjects
0301 basic medicine ,Phage display ,medicine.medical_treatment ,viruses ,Chemistry, Pharmaceutical ,Antibiotics ,lcsh:Medicine ,Artificial Gene Amplification and Extension ,Polymerase Chain Reaction ,Bacteriophage ,Phage Display ,Degree Celsius ,Medicine and Health Sciences ,Bacteriophages ,lcsh:Science ,Phylogeny ,Data Management ,Skin ,Uncategorized ,Viral Genomics ,Multidisciplinary ,biology ,Antimicrobials ,Drugs ,Genomics ,Cetomacrogol ,Molecular Biology Display Techniques ,Phylogenetics ,Viruses ,Research Article ,Computer and Information Sciences ,Phage therapy ,medicine.drug_class ,030106 microbiology ,Molecular Sequence Data ,Microbial Genomics ,Dermatology ,Research and Analysis Methods ,Microbiology ,03 medical and health sciences ,Propionibacterium acnes ,Virology ,Microbial Control ,medicine ,Genetics ,Humans ,Evolutionary Systematics ,Molecular Biology Techniques ,Gene Prediction ,Molecular Biology ,Taxonomy ,Pharmacology ,Molecular Biology Assays and Analysis Techniques ,Evolutionary Biology ,Base Sequence ,lcsh:R ,Organisms ,Biology and Life Sciences ,Computational Biology ,Sequence Analysis, DNA ,biology.organism_classification ,Genome Analysis ,030104 developmental biology ,Acne ,DNA, Viral ,lcsh:Q ,Sequence Alignment ,Bacteria - Abstract
Aims To isolate and characterise phage which could lyse P. acnes and to formulate the phage into a delivery form for potential application in topical treatment of acne infection. Methods and Results Using standard phage isolation techniques, ten phage capable of lysing P. acnes were isolated from human skin microflora. Their genomes showed high homology to previously reported P. acnes phage. These phage were formulated into cetomacrogol cream aqueous at a concentration of 2.5x108 PFU per gram, and shown to lyse underlying P. acnes cells grown as lawn cultures. These phage formulations remained active for at least 90 days when stored at four degrees Celsius in a light protected container. Conclusions P. acnes phage formulated into cetomacrogol cream aqueous will lyse surrounding and underlying P. acnes bacteria, and are effective for at least 90 days if stored appropriately. Significance and Impact of the Study There are few reports of phage formulation into semi solid preparations for application as phage therapy. The formulation method described here could potentially be applied topically to treat human acne infections. The potential exists for this model to be extended to other phage applied to treat other bacterial skin infections.
- Published
- 2023
- Full Text
- View/download PDF
5. Characterization and formulation into solid dosage forms of a novel bacteriophage lytic against Klebsiella oxytoca
- Author
-
Peter Lock, Teagan L. Brown, Hiu Tat Chan, Dannielle Hoyle, Steve Petrovski, and Joseph Tucci
- Subjects
0301 basic medicine ,Lysis ,Genes, Viral ,Klebsiella pneumoniae ,Antibiotics ,lcsh:Medicine ,Pathology and Laboratory Medicine ,Biochemistry ,law.invention ,Klebsiella Pneumoniae ,Bacteriophage ,law ,Klebsiella ,Medicine and Health Sciences ,Bacteriophages ,lcsh:Science ,Uncategorized ,Dosage Forms ,Multidisciplinary ,biology ,Antimicrobials ,Klebsiella oxytoca ,Drugs ,Genomics ,Recombinant Proteins ,Bacterial Pathogens ,Lytic cycle ,Medical Microbiology ,Viruses ,Recombinant DNA ,Pathogens ,Research Article ,Diarrhea ,medicine.drug_class ,030106 microbiology ,Gastroenterology and Hepatology ,Microbiology ,03 medical and health sciences ,Signs and Symptoms ,Microscopy, Electron, Transmission ,Diagnostic Medicine ,Microbial Control ,DNA-binding proteins ,medicine ,Genetics ,Gene Prediction ,Microbial Pathogens ,Pharmacology ,Bacteria ,lcsh:R ,Organisms ,Biology and Life Sciences ,Proteins ,Computational Biology ,biology.organism_classification ,Genome Analysis ,Virology ,030104 developmental biology ,lcsh:Q - Abstract
Aim To isolate and characterize bacteriophage lytic for the opportunistic pathogen Klebsiella oxytoca and their formulation into a range of solid dosage forms for in-vitro testing. Methods and results We report the isolation, genomic and functional characterization of a novel bacteriophage lytic for Klebsiella oxytoca, which does not infect the closely related Klebsiella pneumoniae. This bacteriophage was formulated into suppositories and troches and shown to be released and lyse underlying Klebsiella oxytoca bacteria in an in-vitro model. These bacteriophage formulations were stable for at least 49 days at 4°C. Conclusions The successful in-vitro assay of these formulations here suggests that they could potentially be tested in-vivo to determine whether such a therapeutic approach could modulate the gut microbiome, and control Klebsiella oxytoca overgrowth, during antibiotic therapy regimes. Significance and impact of the study This study reports a novel bacteriophage specific for Klebsiella oxytoca which can be formulated into solid dosage forms appropriate for potential delivery in testing as a therapy to modulate gut microbiome during antibiotic therapies.
- Published
- 2023
- Full Text
- View/download PDF
6. Ecological and functional roles of bacteriophages in contrasting environments: marine, terrestrial and human gut
- Author
-
Teagan L Brown, Oliver J Charity, and Evelien M Adriaenssens
- Subjects
Microbiology (medical) ,Infectious Diseases ,Bacteria ,Humans ,Metagenome ,Bacteriophages ,Metagenomics ,Genome, Viral ,Microbiology - Abstract
While they are the most abundant biological entities on the planet, the role of bacteriophages (phages) in the microbiome remains enigmatic and understudied. With a rise in the number of metagenomics studies and the publication of highly efficient phage mining programmes, we now have extensive data on the genomic and taxonomic diversity of (mainly) DNA bacteriophages in a wide range of environments. In addition, the higher throughput and quality of sequencing is allowing for strain-level reconstructions of phage genomes from metagenomes. These factors will ultimately help us to understand the role these phages play as part of specific microbial communities, enabling the tracking of individual virus genomes through space and time. Using lessons learned from the latest metagenomic studies, we focus on two explicit aspects of the role bacteriophages play within the microbiome, their ecological role in structuring bacterial populations, and their contribution to microbiome functioning by encoding auxiliary metabolism genes.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.